Work

Correction: Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer

Year: 2018

Type: erratum

Abstract: [This corrects the article DOI: 10.18632/oncotarget.13466.].

Source: Oncotarget

DOI: 10.18632/oncotarget.25151

Authors: Rebecca C. Arend, Angelina I. Londoño-Joshi, Abhishek Gangrade, Ashwini A. Katre, Chandrika Kurpad, Yonghe Li, Rajeev S. Samant, Pui-Kai Li, Charles N. Landen, Eddy S. Yang, Bertha Hidalgo, Ronald D. Alvarez, John Michael Straughn, Andres Forero, Donald J. Buchsbaum

Institutions: University of Alabama at Birmingham, UAB Medicine, Southern Research Institute, The Ohio State University, University of Virginia

Language: English

Topic: Wnt/β-catenin signaling in development and cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: diamond

Funders: Robert Wood Johnson Foundation, National Institutes of Health, National Heart, Lung, and Blood Institute, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: Research Training Program in Basic and Translational Oncology, G3631496366, G9000313782, UAB Diabetes Research Center

OpenAlex ID: W4210950848

Cites:

Cited by: 1

Related to: 10